Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2023

Open Access 01-12-2023 | Testosterone | Case Report

Modulatory activity of testosterone on growth pattern and IGF-1 levels in vanishing testis syndrome: a case report during 15 years of follow-up

Authors: Marta Franco, Keyvan Khorrami Chokami, Manuela Albertelli, Claudia Teti, Francesco Cocchiara, Federico Gatto, Carlo Trombetta, Diego Ferone, Mara Boschetti

Published in: BMC Endocrine Disorders | Issue 1/2023

Login to get access

Abstract

Background

The vanishing testis syndrome (VTS), is a 46, XY disorder of sex development (46, XY DSD) and is characterized by the absence of testis in a 46, XY subject with male genitalia, gonadal dysgenesis and consequent hypergonadotropic hypogonadism.

Case presentation

A young man affected by VTS has been followed up for more than 15-year in our center. The patient received different testosterone formulations, which modulated his IGF-1 levels and height velocity, depending on different stimulatory effects, mimicking pubertal spurt until achieving a final height in line with his genetic target.
Exogenous testosterone, activating GH/IGF-1 system, can directly influence growth pattern. With this particular case report we demonstrate that an accurate monitoring of patients with VTS, as well as a perfect reproduction of testosterone secretion during pubertal spurt, can guarantee a normal growth and development and, consequently, a high level of quality of life in adulthood.

Conclusion

Testosterone levels act an important role during pubertal spurt in modulating the GH/IGF-1 axis, besides its well-known impact in sexual development.
Very little amount of exogenous testosterone can stimulate IGF-1 secretion and provide to growth velocity the drive that characterizes the initial phases of the growth spurt.
Literature
1.
go back to reference Houk CP, Hughes IA, Ahmed SF, Lee PA. Writing Committee for the International Intersex Consensus Conference P: Summary of consensus statement on intersex disorders and their management. International Intersex Consensus Conference Pediatrics. 2006;118(2):753–7. Houk CP, Hughes IA, Ahmed SF, Lee PA. Writing Committee for the International Intersex Consensus Conference P: Summary of consensus statement on intersex disorders and their management. International Intersex Consensus Conference Pediatrics. 2006;118(2):753–7.
2.
go back to reference Woodford E, Eliezer D, Deshpande A, Kumar R. Is excision of testicular nubbin necessary in vanishing testis syndrome? J Pediatr Surg. 2018;53(12):2495–7.CrossRef Woodford E, Eliezer D, Deshpande A, Kumar R. Is excision of testicular nubbin necessary in vanishing testis syndrome? J Pediatr Surg. 2018;53(12):2495–7.CrossRef
3.
go back to reference Igarashi A, Kikuchi K, Ogushi K, Hasegawa M, Hatanaka M, Fujino J, Kishi Y, Ikeda H. Surgical exploration for impalpable testis: Which should be first, inguinal exploration or laparoscopic abdominal exploration? J Pediatr Surg. 2018;53(9):1766–9.CrossRef Igarashi A, Kikuchi K, Ogushi K, Hasegawa M, Hatanaka M, Fujino J, Kishi Y, Ikeda H. Surgical exploration for impalpable testis: Which should be first, inguinal exploration or laparoscopic abdominal exploration? J Pediatr Surg. 2018;53(9):1766–9.CrossRef
4.
go back to reference Tekant G, Emir H, Froglu E, Akman M, Buyukunal C, Danismend N, Soylet Y. Experience with laparoscopy in nonpalpable testis. Horm Res. 2001;55(1):52. Tekant G, Emir H, Froglu E, Akman M, Buyukunal C, Danismend N, Soylet Y. Experience with laparoscopy in nonpalpable testis. Horm Res. 2001;55(1):52.
5.
go back to reference Diamond DA, Caldamone AA, Elder JS. Prevalence of the vanishing testis in boys with a unilateral impalpable testis: is the side of presentation significant? J Urol. 1994;152(2 Pt 1):502–3.CrossRef Diamond DA, Caldamone AA, Elder JS. Prevalence of the vanishing testis in boys with a unilateral impalpable testis: is the side of presentation significant? J Urol. 1994;152(2 Pt 1):502–3.CrossRef
6.
go back to reference Zenaty D, Dijoud F, Morel Y, Cabrol S, Mouriquand P, Nicolino M, Bouvatier C, Pinto G, Lecointre C, Pienkowski C, et al. Bilateral anorchia in infancy: occurence of micropenis and the effect of testosterone treatment. J Pediatr. 2006;149(5):687–91.CrossRef Zenaty D, Dijoud F, Morel Y, Cabrol S, Mouriquand P, Nicolino M, Bouvatier C, Pinto G, Lecointre C, Pienkowski C, et al. Bilateral anorchia in infancy: occurence of micropenis and the effect of testosterone treatment. J Pediatr. 2006;149(5):687–91.CrossRef
7.
go back to reference Hegarty PK, Mushtaq I, Sebire NJ. Natural history of testicular regression syndrome and consequences for clinical management. J Pediatr Urol. 2007;3(3):206–8.CrossRef Hegarty PK, Mushtaq I, Sebire NJ. Natural history of testicular regression syndrome and consequences for clinical management. J Pediatr Urol. 2007;3(3):206–8.CrossRef
8.
go back to reference Spires SE, Woolums CS, Pulito AR, Spires SM. Testicular regression syndrome: a clinical and pathologic study of 11 cases. Arch Pathol Lab Med. 2000;124(5):694–8.CrossRef Spires SE, Woolums CS, Pulito AR, Spires SM. Testicular regression syndrome: a clinical and pathologic study of 11 cases. Arch Pathol Lab Med. 2000;124(5):694–8.CrossRef
9.
go back to reference de Grouchy J, Gompel A, Salomon-Bernard Y, Kuttenn F, Yaneva H, Paniel JB, Le Merrer M, Roubin M. Doussau de Bazignan M, Turleau C: Embryonic testicular regression syndrome and severe mental retardation in sibs. Ann Genet. 1985;28(3):154–60. de Grouchy J, Gompel A, Salomon-Bernard Y, Kuttenn F, Yaneva H, Paniel JB, Le Merrer M, Roubin M. Doussau de Bazignan M, Turleau C: Embryonic testicular regression syndrome and severe mental retardation in sibs. Ann Genet. 1985;28(3):154–60.
10.
go back to reference Wilhelm D, Koopman P. The makings of maleness: towards an integrated view of male sexual development. Nat Rev Genet. 2006;7(8):620–31.CrossRef Wilhelm D, Koopman P. The makings of maleness: towards an integrated view of male sexual development. Nat Rev Genet. 2006;7(8):620–31.CrossRef
11.
go back to reference Josso N, Briard ML. Embryonic testicular regression syndrome: variable phenotypic expression in siblings. J Pediatr. 1980;97(2):200–4.CrossRef Josso N, Briard ML. Embryonic testicular regression syndrome: variable phenotypic expression in siblings. J Pediatr. 1980;97(2):200–4.CrossRef
12.
go back to reference Rousso I, Iliopoulos D, Athanasiadou F, Zavopoulou L, Vassiliou G, Voyiatzis N. Congenital bilateral anorchia: hormonal, molecular and imaging study of a case. Genetics and molecular research : GMR. 2006;5(4):638–42. Rousso I, Iliopoulos D, Athanasiadou F, Zavopoulou L, Vassiliou G, Voyiatzis N. Congenital bilateral anorchia: hormonal, molecular and imaging study of a case. Genetics and molecular research : GMR. 2006;5(4):638–42.
13.
go back to reference Abeyaratne MR, Aherne WA, Scott JE. The vanishing testis. Lancet. 1969;2(7625):822–4.CrossRef Abeyaratne MR, Aherne WA, Scott JE. The vanishing testis. Lancet. 1969;2(7625):822–4.CrossRef
14.
go back to reference Pirgon O, Dundar BN. Vanishing testes: a literature review. J Clin Res Pediatr Endocrinol. 2012;4(3):116–20.CrossRef Pirgon O, Dundar BN. Vanishing testes: a literature review. J Clin Res Pediatr Endocrinol. 2012;4(3):116–20.CrossRef
15.
go back to reference Sohval AR. The Syndrome of Pure Gonadal Dysgenesis. Am J Med. 1965;38:615–25.CrossRef Sohval AR. The Syndrome of Pure Gonadal Dysgenesis. Am J Med. 1965;38:615–25.CrossRef
16.
go back to reference Aubert L, Laroche C, Caquet R, Sizonenko P, Thezet R. Pure gonadal dysgenesis with normal stature, skeletal anomalies and XX-XO mosaicism. La Presse medicale. 1966;74(50):2589–94. Aubert L, Laroche C, Caquet R, Sizonenko P, Thezet R. Pure gonadal dysgenesis with normal stature, skeletal anomalies and XX-XO mosaicism. La Presse medicale. 1966;74(50):2589–94.
17.
go back to reference Moorthy B, Papadopolou M, Shaw DG, Grant DB. Depot testosterone in boys with anorchia or gonadotrophin deficiency: effect on growth rate and adult height. Arch Dis Child. 1991;66(2):197–9.CrossRef Moorthy B, Papadopolou M, Shaw DG, Grant DB. Depot testosterone in boys with anorchia or gonadotrophin deficiency: effect on growth rate and adult height. Arch Dis Child. 1991;66(2):197–9.CrossRef
18.
go back to reference Illig R, Prader A. Effect of testosterone on growth hormone secretion in patients with anorchia and delayed puberty. J Clin Endocrinol Metab. 1970;30(5):615–8.CrossRef Illig R, Prader A. Effect of testosterone on growth hormone secretion in patients with anorchia and delayed puberty. J Clin Endocrinol Metab. 1970;30(5):615–8.CrossRef
19.
go back to reference Heksch RA, Matheson MA, Tishelman AC, Swartz JM, Jayanthi VR, Diamond DA, Harrison CJ, Chan YM, Nahata L: Testicular Regression Syndrome: Practice Variation in Diagnosis and Management. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2019. Heksch RA, Matheson MA, Tishelman AC, Swartz JM, Jayanthi VR, Diamond DA, Harrison CJ, Chan YM, Nahata L: Testicular Regression Syndrome: Practice Variation in Diagnosis and Management. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2019.
20.
go back to reference Bader MI, Peeraully R, Ba’ath M, McPartland J, Baillie C. The testicular regression syndrome–do remnants require routine excision? J Pediatr Surg. 2011;46(2):384–6.CrossRef Bader MI, Peeraully R, Ba’ath M, McPartland J, Baillie C. The testicular regression syndrome–do remnants require routine excision? J Pediatr Surg. 2011;46(2):384–6.CrossRef
21.
go back to reference Antic T, Hyjek EM, Taxy JB. The vanishing testis: a histomorphologic and clinical assessment. Am J Clin Pathol. 2011;136(6):872–80.CrossRef Antic T, Hyjek EM, Taxy JB. The vanishing testis: a histomorphologic and clinical assessment. Am J Clin Pathol. 2011;136(6):872–80.CrossRef
22.
go back to reference Papparella A, Romano M, Noviello C, Cobellis G, Nino F, Del Monaco C, Parmeggiani P. The value of laparoscopy in the management of non-palpable testis. J Pediatr Urol. 2010;6(6):550–4.CrossRef Papparella A, Romano M, Noviello C, Cobellis G, Nino F, Del Monaco C, Parmeggiani P. The value of laparoscopy in the management of non-palpable testis. J Pediatr Urol. 2010;6(6):550–4.CrossRef
23.
go back to reference Radmayr C. Management of undescended testes: European Association of Urology/European Society for Paediatric Urology guidelines. J Pediatr Urol. 2017;13(5):550.CrossRef Radmayr C. Management of undescended testes: European Association of Urology/European Society for Paediatric Urology guidelines. J Pediatr Urol. 2017;13(5):550.CrossRef
24.
go back to reference Esposito C, Escolino M, Savanelli A, Alicchio F, Roberti A, Settimi A. Ultrasonography is unnecessary and misleading in evaluating boys with a nonpalpable testis and can be a cause of a legal process. Med Sci Law. 2013;53(4):247–8.CrossRef Esposito C, Escolino M, Savanelli A, Alicchio F, Roberti A, Settimi A. Ultrasonography is unnecessary and misleading in evaluating boys with a nonpalpable testis and can be a cause of a legal process. Med Sci Law. 2013;53(4):247–8.CrossRef
25.
go back to reference Lee PA, Nordenstrom A, Houk CP, Ahmed SF, Auchus R, Baratz A, Baratz Dalke K, Liao LM, Lin-Su K, Looijenga LH 3rd, et al. Global Disorders of Sex Development Update since 2006: Perceptions, Approach and Care. Hormone research in paediatrics. 2016;85(3):158–80.CrossRef Lee PA, Nordenstrom A, Houk CP, Ahmed SF, Auchus R, Baratz A, Baratz Dalke K, Liao LM, Lin-Su K, Looijenga LH 3rd, et al. Global Disorders of Sex Development Update since 2006: Perceptions, Approach and Care. Hormone research in paediatrics. 2016;85(3):158–80.CrossRef
26.
go back to reference Rogol AD, Swerdloff RS, Reiter EO, Ross JL, ZumBrunnen TL, Pratt GA, Brennan JJ, Benesh J, Kan-Dobrosky N, Miller MG. A multicenter, open-label, observational study of testosterone gel (1%) in the treatment of adolescent boys with klinefelter syndrome or anorchia. The Journal of adolescent health : official publication of the Society for Adolescent Medicine. 2014;54(1):20–5.CrossRef Rogol AD, Swerdloff RS, Reiter EO, Ross JL, ZumBrunnen TL, Pratt GA, Brennan JJ, Benesh J, Kan-Dobrosky N, Miller MG. A multicenter, open-label, observational study of testosterone gel (1%) in the treatment of adolescent boys with klinefelter syndrome or anorchia. The Journal of adolescent health : official publication of the Society for Adolescent Medicine. 2014;54(1):20–5.CrossRef
27.
go back to reference Shoskes JJ, Wilson MK, Spinner ML. Pharmacology of testosterone replacement therapy preparations. Translational andrology and urology. 2016;5(6):834–43.CrossRef Shoskes JJ, Wilson MK, Spinner ML. Pharmacology of testosterone replacement therapy preparations. Translational andrology and urology. 2016;5(6):834–43.CrossRef
28.
go back to reference Craft WH, Underwood LE. Effect of androgens on plasma somatomedin-C/insulin-like growth factor I responses to growth hormone. Clin Endocrinol. 1984;20(5):549–54.CrossRef Craft WH, Underwood LE. Effect of androgens on plasma somatomedin-C/insulin-like growth factor I responses to growth hormone. Clin Endocrinol. 1984;20(5):549–54.CrossRef
29.
go back to reference Martin LG, Grossman MS, Connor TB, Levitsky LL, Clark JW, Camitta FD. Effect of androgen on growth hormone secretion and growth in boys with short stature. Acta Endocrinol. 1979;91(2):201–12. Martin LG, Grossman MS, Connor TB, Levitsky LL, Clark JW, Camitta FD. Effect of androgen on growth hormone secretion and growth in boys with short stature. Acta Endocrinol. 1979;91(2):201–12.
30.
go back to reference Daughaday WH, Hall K, Raben MS, Salmon WD Jr, van den Brande JL, van Wyk JJ. Somatomedin: proposed designation for sulphation factor. Nature. 1972;235(5333):107.CrossRef Daughaday WH, Hall K, Raben MS, Salmon WD Jr, van den Brande JL, van Wyk JJ. Somatomedin: proposed designation for sulphation factor. Nature. 1972;235(5333):107.CrossRef
31.
go back to reference Isgaard J, Moller C, Isaksson OG, Nilsson A, Mathews LS, Norstedt G. Regulation of insulin-like growth factor messenger ribonucleic acid in rat growth plate by growth hormone. Endocrinology. 1988;122(4):1515–20.CrossRef Isgaard J, Moller C, Isaksson OG, Nilsson A, Mathews LS, Norstedt G. Regulation of insulin-like growth factor messenger ribonucleic acid in rat growth plate by growth hormone. Endocrinology. 1988;122(4):1515–20.CrossRef
32.
go back to reference Jansson JO, Eden S, Isaksson O. Sites of action of testosterone and estradiol on longitudinal bone growth. Am J Physiol. 1983;244(2):E135-140. Jansson JO, Eden S, Isaksson O. Sites of action of testosterone and estradiol on longitudinal bone growth. Am J Physiol. 1983;244(2):E135-140.
33.
go back to reference Zung A, Phillip M, Chalew SA, Palese T, Kowarski AA, Zadik Z. Testosterone effect on growth and growth mediators of the GH-IGF-I axis in the liver and epiphyseal growth plate of juvenile rats. J Mol Endocrinol. 1999;23(2):209–21.CrossRef Zung A, Phillip M, Chalew SA, Palese T, Kowarski AA, Zadik Z. Testosterone effect on growth and growth mediators of the GH-IGF-I axis in the liver and epiphyseal growth plate of juvenile rats. J Mol Endocrinol. 1999;23(2):209–21.CrossRef
34.
go back to reference Attie KM, Ramirez NR, Conte FA, Kaplan SL, Grumbach MM. The pubertal growth spurt in eight patients with true precocious puberty and growth hormone deficiency: evidence for a direct role of sex steroids. J Clin Endocrinol Metab. 1990;71(4):975–83.CrossRef Attie KM, Ramirez NR, Conte FA, Kaplan SL, Grumbach MM. The pubertal growth spurt in eight patients with true precocious puberty and growth hormone deficiency: evidence for a direct role of sex steroids. J Clin Endocrinol Metab. 1990;71(4):975–83.CrossRef
35.
go back to reference Murray PG, Clayton PE. Endocrine control of growth. Am J Med Genet C Semin Med Genet. 2013;163C(2):76–85.CrossRef Murray PG, Clayton PE. Endocrine control of growth. Am J Med Genet C Semin Med Genet. 2013;163C(2):76–85.CrossRef
36.
go back to reference Yoshizawa A, Clemmons DR. Testosterone and insulin-like growth factor (IGF) I interact in controlling IGF-binding protein production in androgen-responsive foreskin fibroblasts. J Clin Endocrinol Metab. 2000;85(4):1627–33. Yoshizawa A, Clemmons DR. Testosterone and insulin-like growth factor (IGF) I interact in controlling IGF-binding protein production in androgen-responsive foreskin fibroblasts. J Clin Endocrinol Metab. 2000;85(4):1627–33.
Metadata
Title
Modulatory activity of testosterone on growth pattern and IGF-1 levels in vanishing testis syndrome: a case report during 15 years of follow-up
Authors
Marta Franco
Keyvan Khorrami Chokami
Manuela Albertelli
Claudia Teti
Francesco Cocchiara
Federico Gatto
Carlo Trombetta
Diego Ferone
Mara Boschetti
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2023
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-022-01258-2

Other articles of this Issue 1/2023

BMC Endocrine Disorders 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine